• ‘Rare Impact Awards’ Dinner Marks Orphan Drug Act and NORD at 35
  • #ECRD2018 – EU Must Do More for Rare Disease Patients, Eurordis Leaders Say
  • SmartVest System Leads to Long-term Benefits for Bronchiectasis Patients, Study Shows
  • International Biophysics’ AffloVest Airway Clearance Vest Awarded New US Patents
  • #ECRD2018 – Patient Access and Collaboration Focus of Eurordis Meeting May 10-12
  • Bronchiectasis Associated with Acute COPD Exacerbations, Study Shows
  • Insmed Research Award Created for Non-Tuberculosis Mycobacteria Lung Disease Projects
  • NIH Agency Pioneers Collaborative Research into Rare Diseases
  • Severe Asthma Patients with Bronchiectasis at Increased Risk of Hospitalization, Other Issues, Study Finds
  • European Regulators Agree to Review Aradigm’s Bronchiectasis Bacteria Therapy
  • Bronchiectasis Patients with P. Aeruginosa Show Worse Lung Function, Lower Quality of Life in Study
  • New Scoring System Helps Predict Bronchiectasis in Patients with Uncontrolled Asthma, Study Shows